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The assessment of balance in multiple sclerosis can be done in practice with
clinical tests. It may be supplemented by instrumental tests that help to better
understand the origin and evolution under treatment.
The aim of rehabilitation in patients with multiple sclerosis is determined
by the level of impairment. In less affected patients, an improvement can be
expected in balance. Specific rehabilitation program seems to be more accurate
than non-specific training programs. Cognitive and motor impairments are the
most limiting factors in the most advanced stages of the diseases.
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Objective.– To define the place of patient therapeutic education (PTE) into
multiple sclerosis management.
Methods.– Systematic literature review in PubMed and Cochrane Library
databases from 1966 to 2010 with the keywords “multiple sclerosis”, “self-
care”, “self-management”. Clinical trials and studies in English, French, and
literature reviews and practice guidelines are analyzed.
Results.– Several studies concern general health (7 studies), fatigue management
(12 studies) or pain (7 studies). There are less studies concerning prevention of
falls (1 study), cognitive disorders, mood and behavior (3 studies) and genito-
sexual disorders (1 study).
Conclusion.– TPE is part of the management of MS, particularly through the
practice of physical activity and fatigue management. It is also essential to
validate information content and to develop educational tools for MS patients.
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Objective.– To characterize walking fatigability in Multiple sclerosis (MS)
patients.
Methods.– Seventy-six patients (51.1 ± 11 yo; median EDSS = 5, min = 4–max =
6.5) performed the Timed 25-Foot Walk Test (T25FWT), the 2-minute Walk Test
(2MWT) and five successive trials at maximum walking speed on a GAITRITE
electronic walkway (8 m).
Results.– In the low EDSS group (4–5; n = 46), walking fatigability was only
observed for the 2MWT (–0.12 m.s−1 that is–11% between the first and last
quarter of the test). In the high EDSS group, absolute decrease in walking speed
was not different compared to the low EDSS group (–0.12 m.s−1), but fatiga-
bility was higher relatively to initial walking speed (–19%; P = 0.018). Walking
distance for the 2MWT was significantly lower in the high EDSS group (72
vs 117 m; P < 0.001). In both groups, walking fatigability was mainly due to a
decrease in walking cadence.
Discussion.– Absolute gait fatigability seems to be independent of functional
status in MS patients, at least for short to middle walking distances. This empha-
sizes the role of walking speed and cadence training in rehabilitation programs
in MS patients.
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Objective.– To assess efficacy of fampridine on walking parameters, hand func-
tion, fatigue and quality of life (QoL) in patients with multiple sclerosis (MS).
Methods.– Hundred and eleven consecutive patients eligible for fampridine treat-
ment were evaluated before and after 2 weeks (W2) of treatment, and finally after
3 months (M3) for responders. Response criteria were defined as an improve-
ment of at least 15% in the Timed-25-Foot-Walk (T25FW), the 2-Minute Walk
Test (2MWT) or the MS Walking Scale (MSWS-12). Moreover, we performed
an analysis of spatio-temporal gait parameters (GAITRITE), and assessments
of fatigue (Visual Analog Scale (VAS), hand function (Nine Hole Peg Test) and
QoL (SF-12).
Results.– Eighty-five patients (76.6%) were found to be responders, improving
T25FW by 33.6% at W2 (vs 4.8% in non-responders) and 31.8% at M3, 2MWT
by 38.4% (vs8.5%) and 35.6% and MSWS by 18%. Furthermore, responders
showed an amelioration of fatigue severity (P < 0.01), hand function (P < 0.05)
and QoL (P < 0.001).
Discussion.– In responders, fampridine improves walking, but also other general
symptoms and QoL. It could be of interest in the rehabilitation of MS patients.
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Background.– Fatigue and depression are the most common problems in multiple
sclerosis (MS) and strong associations have been reported between them in
numerous studies. The purpose of the study was to investigate the seasonal
variation of fatigue and depression during every season of the year in a Greek
sample of MS patients.
Methods.– Forty-five patients with MS participated in the study. Measurements
of fatigue and depression were made with fatigue severity scale (FSS) and Beck
depression Inventory (BDI) respectively. The measurements were conducted
every three months (November, February, May and August) on the last day
of each month during a year. Mean value (M) of fatigue for MS patients was
(M = 4.20 SE = 0.22.).
Results.– No significant fluctuation of fatigue and depression were observed
in patients with MS. This finding confirms previous reports of fatigue and
depression stability on 6-month basis.
